RE:RE:RE:NasdaqBucknelly21 wrote: In the proper order the sp will be well above what it needs to be and by the look of the market Nash is about the hottest thing in pharma at the moment
I think I speak for many frustrated share holders ... "SHOW ME THE MONEY!!" I've heard the "just wait until ____" speech far too many times ...
- wait until they submit the application to FDA
- wait until the application is offically accepted
- wait until the factories are inspected
- wait to get through the FDA extended approval schedule
- wait until drug approval
- wait until the drug is on the market
- wait until the insurance reimbursement is set up
- wait until the drug is on some "easy reimbursement program" (I forgot the name of that list that happened on Jan 1)
- wait until the sales pick up
- wait until the earnings call
- wait until the earnings call
- wait until the earnings call
- wait until the earnings call
- wait until the investor conference
- wait until a new presentation is available
- wait until they submit the application in Europe
- wait until the recommendation <from some committee in Euope> is received
- wait until it is approved in Europe
- wait until they set up an office in Europe
- wait until we have dinner with the Board so we can give them advice
- wait until some liver specialist (who has become an analyst) writes an important article that MANY people will read and respond to
- wait until we get top line NASH data
- wait until the NASH paper is published
- wait until the company lays out the NASH plan
- wait until a NASDAQ listing
- wait until "everyone else in the world knows what we know"
- wait until they buy the rights to a third drug
- wait until the "crazy market" does what it should
Anyone see a pattern here? Did I miss any?
-LT